DaVita Inc.
NYSE:DVA · New York Stock Exchange
+$1.60 today
Vol 0.58M · Avg 0.84M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:DVA · Revenue to Net Income
Key Ratios
Analysis
$13.8B of revenue converted into $781.4M of net income for the selected period. Gross margin is 31.1% and net margin is 5.6%, showing how much revenue survives after costs and taxes. EPS is $9.94, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.6B +6.5% | $12.8B +5.6% | $12.1B +4.6% | $11.6B -0.1% | $11.6B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $10.0B +15.8% | $8.6B +3.4% | $8.3B +1.3% | $8.2B +3.0% | $8.0B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $3.7B -12.6% | $4.2B +10.4% | $3.8B +12.4% | $3.4B -6.7% | $3.6B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 27.0% -5.9pp | 32.9% +1.4pp | 31.5% +2.2pp | 29.3% -2.1pp | 31.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.7B +8.8% | $1.5B +4.4% | $1.5B +8.8% | $1.4B +13.4% | $1.2B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.7B -21.3% | $2.1B -4.1% | $2.2B +7.6% | $2.1B +11.5% | $1.8B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $715.3M -1.2% | $723.9M -2.9% | $745.4M +1.8% | $732.6M +7.6% | $680.6M | $374.2M | $1.2B | $631.8M |
| EBITDA | $2.6B -3.0% | $2.7B +17.4% | $2.3B +12.9% | $2.1B -17.2% | $2.5B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 19.4% -1.9pp | 21.3% +2.1pp | 19.1% +1.4pp | 17.7% -3.7pp | 21.4% | 5.6% | 46.3% | 42.0% |
| Operating Income | $2.0B -3.8% | $2.1B +30.4% | $1.6B +19.7% | $1.3B -25.5% | $1.8B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 14.7% -1.6pp | 16.3% +3.1pp | 13.2% +1.7pp | 11.5% -3.9pp | 15.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $549.7M +16.8% | $470.5M +18.0% | $398.6M +11.6% | $357.0M +25.2% | $285.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$663.8M -18.5% | -$560.1M -31.6% | -$425.7M -14.2% | -$372.8M -33.7% | -$278.9M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.3B -12.0% | $1.5B +30.0% | $1.2B +21.8% | $966.3M -36.4% | $1.5B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 9.9% -2.1pp | 11.9% +2.2pp | 9.7% +1.4pp | 8.3% -4.7pp | 13.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $293.1M +4.8% | $279.7M +27.0% | $220.1M +11.1% | $198.1M -35.4% | $306.7M | $1.3B | -$1.6B | $745.2M |
| Net Income | $746.8M -20.2% | $936.3M +35.4% | $691.5M +23.4% | $560.4M -42.7% | $978.5M | $4.9B | $4.8B | $4.7B |
| Net Margin | 5.5% -1.8pp | 7.3% +1.6pp | 5.7% +0.9pp | 4.8% -3.6pp | 8.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $10 -11.8% | $11 +44.6% | $8 +29.6% | $6 -36.8% | $9 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $10 -11.4% | $11 +44.6% | $7 +29.9% | $6 -35.8% | $9 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $86.1M +1.3% | $85.0M -6.4% | $90.8M -2.4% | $93.0M -11.6% | $105.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $88.1M +0.9% | $87.3M -6.3% | $93.2M -2.8% | $95.8M -12.8% | $109.9M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$33.54B
Align Technology, Inc.
NASDAQ:ALGN
$12.43B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.63B
Molina Healthcare, Inc.
NYSE:MOH
$10.19B
Henry Schein, Inc.
NASDAQ:HSIC
$9.11B
The Ensign Group, Inc.
NASDAQ:ENSG
$9.11B
Universal Health Services, Inc.
NYSE:UHS
$8.84B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.70B
AptarGroup, Inc.
NYSE:ATR
$7.66B
Chemed Corporation
NYSE:CHE
$5.79B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does DVA generate?
DaVita Inc. (DVA) reported $13.64B of revenue in fiscal 2025.
Is DVA profitable?
DaVita Inc. (DVA) reported $746.80M of net income, with a net margin of 5.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.